<i>KMT2A</i> partner genes in infant acute lymphoblastic leukemia have prognostic significance and correlate with age, white blood cell count, sex, and central nervous system involvement: a Children’s Oncology Group P9407 trial study

• Blaine W. Robinson,
• John A. Kairalla,
• Meenakshi Devidas,
• Andrew J. Carroll,
• Richard C. Harvey,
• Nyla A. Heerema,
• Cheryl L. Willman,
• Amanda R. Ball,
• Elliot C. Woods,
• Nancy C. Ballantyne,
• Karen A. Urtishak,
• Frederick G. Behm,
• Gregory H. Reaman,
• Joanne M. Hilden,
• Bruce M. Camitta,
• Naomi J. Winick,
• Jeanette Pullen,
• William L. Carroll,
• Stephen P. Hunger,
• ZoAnn E. Dreyer,
• Carolyn A. Felix

Affiliations

Blaine W. Robinson

Division of Oncology and the Center for Childhood Cancer Research, Children’s Hospital of Philadelphia, Philadelphia, PA

John A. Kairalla

Department of Biostatistics, University of Florida College of Public Health and Health Professions and College of Medicine, Gainesville, FL

Meenakshi Devidas

Department of Global Pediatric Medicine, St Jude Children’s Research Hospital, Memphis, TN

Andrew J. Carroll

Department of Genetics, University of Alabama at Birmingham, Birmingham, AL

Richard C. Harvey

University of New Mexico Cancer Center and Department of Pathology, Albuquerque, NM

Nyla A. Heerema

Department of Pathology, The Ohio State University Comprehensive Cancer Center, Columbus, OH

Cheryl L. Willman

Mayo Clinic Comprehensive Cancer Center, Rochester, MN

Amanda R. Ball

Division of Oncology and the Center for Childhood Cancer Research, Children’s Hospital of Philadelphia, Philadelphia, PA

Elliot C. Woods

Division of Oncology and the Center for Childhood Cancer Research, Children’s Hospital of Philadelphia, Philadelphia, PA

Nancy C. Ballantyne

Division of Oncology and the Center for Childhood Cancer Research, Children’s Hospital of Philadelphia, Philadelphia, PA

Karen A. Urtishak

Division of Oncology and the Center for Childhood Cancer Research, Children’s Hospital of Philadelphia, Philadelphia, PA

Frederick G. Behm

Department of Pathology, University of Illinois at Chicago, Chicago, IL

Gregory H. Reaman

Children's National Medical Center, Washington DC

Joanne M. Hilden

Center for Cancer and Blood Disorders, Children’s Hospital Colorado, Aurora, CO

Bruce M. Camitta

Medical College of Wisconsin, Milwaukee, WI

Naomi J. Winick

Division of Pediatric Hematology/Oncology, University of Texas Southwestern School of Medicine, Dallas, TX

Jeanette Pullen

Pediatric Hematology/Oncology, University of Mississippi Medical Center, Jackson, MS

William L. Carroll

Department of Pediatrics and Perlmutter Cancer Center, NYU Langone Health, New York, NY

Stephen P. Hunger

Division of Oncology and the Center for Childhood Cancer Research, Children’s Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

ZoAnn E. Dreyer

Texas Children's Cancer Center, Houston, TX

Carolyn A. Felix

Division of Oncology and the Center for Childhood Cancer Research, Children’s Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA